It's too early for treatment withdrawal after recovery from dilated cardiomyopathy - PACE-CME

Its too early for treatment withdrawal after recovery from dilated cardiomyopathy

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Heart Failure
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
- Jonathan Cunningham, MD
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
Heart Failure
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
- John Ostrominski
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Heart Failure
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
- Akshay S. Desai, MD
NYHA FC and Finerenone Response: Clinical Trial Insights
NYHA FC and Finerenone Response: Clinical Trial Insights
Heart Failure
NYHA FC and Finerenone Response: Clinical Trial Insights
- John Ostrominski